Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125299032 | 12529903 | 2 | F | 20160502 | 20160722 | 20160706 | 20160802 | EXP | GB-BAXTER-2016BAX034072 | BAXTER | 90.00 | YR | M | Y | 0.00000 | 20160802 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125299032 | 12529903 | 1 | PS | WATER FOR INJECTION | WATER | 1 | Intravenous (not otherwise specified) | U | 1605302,1601312 | 18632 | 20 | ML | SOLVENT FOR PARENTERAL USE | ||||||
| 125299032 | 12529903 | 2 | SS | WATER FOR INJECTION | WATER | 1 | Intravenous (not otherwise specified) | U | 1605302,1601312 | 18632 | 20 | ML | SOLVENT FOR PARENTERAL USE | ||||||
| 125299032 | 12529903 | 3 | SS | WATER FOR INJECTION | WATER | 1 | Intravenous (not otherwise specified) | U | 1605302,1601312 | 18632 | 20 | ML | SOLVENT FOR PARENTERAL USE | ||||||
| 125299032 | 12529903 | 4 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | U | K002,L001 | 0 | POWDER FOR SOLUTION FOR INFUSION | ||||||||
| 125299032 | 12529903 | 5 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | U | K002,L001 | 0 | 4.5 | G | POWDER FOR SOLUTION FOR INFUSION | ||||||
| 125299032 | 12529903 | 6 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | U | K002,L001 | 0 | 4.5 | G | POWDER FOR SOLUTION FOR INFUSION | ||||||
| 125299032 | 12529903 | 7 | SS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Unknown | U | U | 1600738,1600730 | 0 | 10 | ML | ||||||
| 125299032 | 12529903 | 8 | SS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Unknown | U | U | 1600738,1600730 | 0 | 10 | ML | ||||||
| 125299032 | 12529903 | 9 | SS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Unknown | U | U | 1600738,1600730 | 0 | 10 | ML |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125299032 | 12529903 | 1 | Medication dilution |
| 125299032 | 12529903 | 4 | Antibiotic therapy |
| 125299032 | 12529903 | 7 | Catheter management |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125299032 | 12529903 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125299032 | 12529903 | Depressed mood | |
| 125299032 | 12529903 | Dyskinesia | |
| 125299032 | 12529903 | Pneumoconiosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125299032 | 12529903 | 2 | 20160502 | 0 | ||
| 125299032 | 12529903 | 3 | 20160502 | 0 | ||
| 125299032 | 12529903 | 5 | 20160502 | 0 | ||
| 125299032 | 12529903 | 6 | 20160502 | 0 | ||
| 125299032 | 12529903 | 8 | 20160502 | 0 | ||
| 125299032 | 12529903 | 9 | 20160502 | 0 |